Related Experiment Video
Updated: Feb 19, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Periprosthetic Hip Joint Infection Involving Fusobacterium nucleatum With Subsequent Isolation of Acinetobacter
Stamatios A Papadakis1, Stavros Lykos1, Dimitrios Pallis1
12nd Department of Orthopaedics, KAT General Hospital of Attica, Athens, GRC.
Abstract:
Periprosthetic joint infection (PJI) is a serious complication following total hip arthroplasty and is most commonly caused by Gram-positive organisms. Infections involving anaerobic bacteria or multidrug-resistant Gram-negative pathogens are rare and particularly challenging to manage. We report a case of periprosthetic hip infection in a female patient in whom Fusobacterium nucleatum (F. nucleatum) was initially isolated, followed by Acinetobacter baumannii (A. baumannii) later in the treatment course. Initial management with debridement, antibiotics, and implant retention (DAIR) was unsuccessful, necessitating implant removal, placement, and subsequent removal of a cement spacer, as well as prolonged targeted antimicrobial therapy, including cefiderocol. Following staged revision arthroplasty, successful infection eradication was achieved with an excellent functional outcome. This report highlights the complexity of PJI management, the potential for microbiologic evolution under antimicrobial pressure, and the importance of tailored surgical and antimicrobial strategies.
Insights
This case study details a challenging periprosthetic hip infection (PJI) caused by evolving bacteria, including Fusobacterium nucleatum and Acinetobacter baumannii. Successful management required staged revision surgery and targeted antibiotics, including cefiderocol.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Periprosthetic joint infection (PJI) is a severe complication of total hip arthroplasty, typically caused by Gram-positive bacteria.
- Infections with anaerobic bacteria or multidrug-resistant Gram-negative pathogens present significant management challenges.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Endocarditis I: Introduction

